VolitionRx prepays $500,000 on Lind convertible note, pauses conversion rights

VolitionRx Limited announced on October 27, 2026 a $500,000 cash prepayment toward the outstanding principal on a senior secured convertible promissory note held by Lind Global Asset Management XII LLC. The note was dated January 15, 2026 and carried an original principal amount of $2,400,000.¹

Following the prepayment, the remaining outstanding balance under the note stood at $706,667.¹ The company said this reduces outstanding principal to only $0.7 million on the $2.4 million note and brings total debt reduction across both notes to over $5.0 million since June 30, 2026.¹

A separate note issued to Lind, dated May 20, 2025 with an original principal of $7,500,000, was fully satisfied in September and is no longer outstanding.¹

As part of a waiver and consent agreement dated October 23, 2026, Lind agreed not to exercise its conversion rights under the note on or prior to January 1, 2027 unless and until the closing price per share of Volition's common stock equals or exceeds $0.275 per share, and the parties agreed to defer the otherwise required monthly repayments for November and December 2026 while continuing to reflect those amounts in outstanding principal until otherwise satisfied.¹

Lind also confirmed that no Event of Default would be deemed to have occurred from non-payment of the deferred amounts, waived related rights, and agreed it would not seek any increased repayment amount prior to January 1, 2027.¹

Chief Executive Officer Cameron Reynolds said the company expects to have the remaining note fully satisfied well in advance of its maturity¹, and added that debt and expense reduction remains a top priority as the company seeks to maximize stockholder value, according to Reynolds.¹